chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Injection area has red bumps around it - left arm; Injection area itches - left arm; Injection area has red bumps around it - left arm; Arm was real sore for 3 days; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was real sore for 3 days), VACCINATION SITE MASS (Injection area has red bumps around it - left arm), VACCINATION SITE PRURITUS (Injection area itches - left arm) and VACCINATION SITE ERYTHEMA (Injection area has red bumps around it - left arm) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy (She had a reaction to some band aids.). Concomitant products included VITAMIN C [ASCORBIC ACID], VITAMIN D NOS and CALCIUM for an unknown indication.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm was real sore for 3 days). On 26-Feb-2021, the patient experienced VACCINATION SITE MASS (Injection area has red bumps around it - left arm), VACCINATION SITE PRURITUS (Injection area itches - left arm) and VACCINATION SITE ERYTHEMA (Injection area has red bumps around it - left arm). The patient was treated with Physical therapy (Heating pad) for Pain in extremity; Physical therapy (Heating pad) for Vaccination site mass; Physical therapy (Heating pad) for Vaccination site pruritus and Physical therapy (Heating pad) for Vaccination site erythema. On 21-Feb-2021, PAIN IN EXTREMITY (Arm was real sore for 3 days) had resolved. At the time of the report, VACCINATION SITE MASS (Injection area has red bumps around it - left arm), VACCINATION SITE PRURITUS (Injection area itches - left arm) and VACCINATION SITE ERYTHEMA (Injection area has red bumps around it - left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
No appetite; Fever of 101 F; Tired and could not get out of bed; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (No appetite), PYREXIA (Fever of 101 F) and FATIGUE (Tired and could not get out of bed) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no historical condition was reported).   On 17-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced DECREASED APPETITE (No appetite), PYREXIA (Fever of 101 F) and FATIGUE (Tired and could not get out of bed). On 18-Feb-2021, DECREASED APPETITE (No appetite), PYREXIA (Fever of 101 F) and FATIGUE (Tired and could not get out of bed) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 f.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sore arm; This is a spontaneous report from a contactable pharmacist (patient) via medical information team. A 69-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration on 24Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported) administered via an unspecified route of administration on 02Jan2021 at single dose for COVID-19 immunization. The patient experienced sore arm on an unspecified date. It was reported that the patient participated in a study where they did antibody testing after the being fully vaccinated and the patient's antibody test was negative for antibodies. The patient would like to know if there would be a chance that his antibodies wore off since it has been three months since he received the second dose of the vaccine. The patient would like to know should he receive a booster dose and stated that when he had the second dose, he did not have any side effects other than a sore arm. The outcome of the event was unknown.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Information has been received from a physician concerning a 12 year old (reported as 11 year old) male who on 23-DEC-1999 and 17-OCT-2002 was vaccinated with the first and second dose of MMR II respectively.  On 18-JAN-2010 the patient experienced mumps.  On 20-JAN-2010, the patient was diagnosed with mumps.  The patient had right parotitis.  His right cheek was swollen.  There were no other symptoms.  On 20-JAN-2010 1st blood work was performed and the results showed IgM <1:10, IgG 8.23 and serum amylase 379.  The patient did not receive the 3rd dose of MMR II.  At the time of the report, the outcome was unknown.  No further information is available.
Fever of 103.4, complete inability to sleep or move due to severe nausea, suspected to have peaked at about a quarter past midnight on 2021/05/02. Roommate noticed (attempted) calls for help after ~10 minutes and administered ice water and 325mg acetaminophen. I?ve since recovered enough to fill out this form starting about 55 after midnight. Fever is down to 102.7 and nausea is reduced; dizzy spells that feel like ?skipping a moment? every minute or two, but reducing with the fever. Chronic cough following suspected covid case last year is significantly worsened, and I feel like stuff is trying to get into my lungs, but the coughs are unproductive.  If the fever reverts, I will administer additional acetaminophen and my roommate will take me to urgent care. My primary care provider is closed at this time.
Absolutely feel so sick that I'm about to die I cannot breathe I cannot eat my throat is so sore I've got a headaches I am sick as a dog and I was doing fine before the shot I had had a month-long illness and got over it and started taking my shots and got sick again
Popping in both elbows; It has worsened over time; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received BNT162b2 (BNT162B2), on 30Oct2021 as dose 2, single (Lot number: FF2590) for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: BNT162b2 (First Dose: , Lot: 301358A), administration date: 09Oct2021, for COVID-19 immunization. The following information was reported: JOINT NOISE (non-serious), outcome "not recovered", described as "Popping in both elbows"; CONDITION AGGRAVATED (non-serious), outcome "not recovered", described as "It has worsened over time". Therapeutic measures were not taken as a result of joint noise, condition aggravated.  Additional information: Caller would not provide any identifiers except phone number. Caller received the first dose of the Pfizer COVID-19 on 09Oct2021 and the second dose on 30Oct2021. He has noticed "popping in both elbows" since he received the vaccine and it has worsened over time. Caller would like to know if this is a side effect of the Pfizer COVID-19 vaccine and how long it may last. Caller clarifies that he does have popping in both elbows. Caller declines to provide any patient identifiers other than his phone number. Caller states it started whenever he got the vaccine shots, well not too long after he got his Pfizer Vaccine Shots. Caller later states he thinks it might have started after his second one and it has gotten worse.   No follow-up attempts are possible. No further information is expected.
Large bumpy rash at injection (1 x 3 inches) for 3 weeks - went away - but severe pain in the arm when patient moves the arm still exists.
Lower back pain; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Lower back pain) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20-2A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced BACK PAIN (Lower back pain). At the time of the report, BACK PAIN (Lower back pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  The patient attributed the lower back pain might be due to poor sleeping position. On 12-Mar-2021, the patient received the second dose.  No treatment information was provided.
Approximately 6 hours after the injection at 6 pm I began to experience right sided ankle pain and swelling and mild chills. The pain peaked about 2 hours later about a 5/10 and was constant. I took 200 mg of Ibuprofen and elevated my foot. The right ankle was visibly swollen and red compared to the left.  Prior to going to bed the pain had mostly resolved. Upon waking up in the morning the pain had entirely resolved. There was some residual stiffness that resolved throughout the course of the day.
55 yo F reported rash with 2-3 cm wheel that first appeared 2-4 hours after 1st dose of Pfizer COVID vaccine.  Rash first appeared on L palm, then right palm, then L foot.  Rash cleared in approximately 1 week.  She endorsed mild pruritis without dyspnea, swelling, wheezing.
received the Covid-19 vaccine at 0705. She reports symptoms of some congestion on R side, in ears, eyes feel "popping" a bit; had this the first time. "I think it is my BP."; takes meds at night. Is drinking water. Denies issues breathing, able to swallow; no hives, itching. 0715 BP 138/84, pulse 78, p ox 100 %; will continue being monitored, resting, eyes closed. 0725 BP 138/86, pulse 70, p ox 98%; feels about the same/maybe a little better;no issues breathing. Continue monitoring.  0730 States still bit congested; feels like "eyes could cross" if let them, a bit dizzy; no vision changes, no issues breathing. Offered to contact Rapid Response for evaluation in ED; patient wants to give another 5 minutes or so.  0735 Patient feels better, less congestion; BP 122/84, p 70. Able to stand without dizziness; feels comfortable going. Brother lives close; may go there. Has papers on when to seek medical attention.
Suspected pneumonitis.  Patient presented on day following vaccination as shortness of breath, nausea, and diarrhea were not abating with home management. They had started later in the day after the vaccination.  At ER admission - SpO2 = 80% room air. Nasal cannula was applied and SpO2 recovered quickly.  BNP was elevated so acute exacerbation of heart failure was suspected and treated. However, patient did not improve with diuresis.  Viral workup and bacterial cause workup negative. No acute cardiac events discovered. Patient continued to decline. Transferred to ICU on 3-19-21 to use BiPAP with 65% FiO2 and able to take breaks to 15L nasal cannula. Borderline blood pressures at this time.  Infectious disease, pulmonology, cardiology, nephrology, and critical care anesthesia services evaluated and ruled out multiple possible diagnoses and patient continued to decline.  Diagnostic bronchoscopy on 3-22-21 with BAL lead to patient ventilator dependent with profound hypotension.  Aggressive ICU management ensued.  Bronchoscopy very clean with no real secretions - in line with CT evidence of pneumonitis.  Despite aggressive care and maximized pressor support, patient expired on 3-29-21 when family chose to withdraw care as blood pressure declined again.
Redness around shot area, swelling around shot area, fever, musclle/joint aches and nausea
RHEUMATOID ARTHRITIS - COURSE AS FOLLOWS:  Immediate localized tenderness at injection site.  Muscle pain within two weeks, attributed to injection and dismissed as minor by phone consultation w nurse.  Bilaterial Carpel Tunnel Syndrome one month post injection - diagnosed during office visit.  Tennis Elbow in left arm one month post injection - diagnosed during office visit.  Rheumatoid arthritis flare 4 months post injection - diagnosed via blood test taken during emergency visit to doctor's office.  Ongoing RA symptoms to current date, including one additional RA flare requiring ER visit.  Current medication treatment:  mevachor, relafen, norco, flexeril, calcium supplement, multivitamin,  folic acid.
Significant neck and upper back pain as soon as 1 hour post vaccine lasting until at least 24 hours - tylenol and heat/ice (no change) chills without fever overnight the night of - no treatment soreness in arm 1 hr post to up to its worst at 24 hours later when I could not abduct >90 degrees for 24 more hours
sore arms where got the shot.; 1st dose about 6 years ago; headache for 3 days; This case was reported by a consumer via interactive digital media and described the occurrence of injection site pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of herpes zoster (For tolerance of 1st dose, refer case US2022AMR123664).   In August 2022, the patient received the 2nd dose of Shingles vaccine. In August 2022, less than a month after receiving Shingles vaccine, the patient experienced injection site pain, headache and drug dose administration interval too long. On an unknown date, the outcome of the injection site pain and drug dose administration interval too long were unknown and the outcome of the headache was recovered/resolved.   It was unknown if the reporter considered the injection site pain and headache to be related to Shingles vaccine.   Linked case(s) involving the same patient:US2022AMR123664   Additional Information: GSK Receipt Date: 22-AUG-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient just had his/her 2nd shingles vaccine a few days ago and the side effects of getting it was not also comfortable.  The patient had a headache for about 3 days and sore arms where he/she got the shot. Additional Supportive Information: The patient received the 2nd dose of shingles vaccine later than the recommended schedule, which led to lengthening of vaccination schedule. The follow up would not possible as no contact details were available.; Sender's Comments:  US-GSK-US2022AMR123664:Same reporter
pt recv vax 22AUG95 & 2APR96 or 3APR96 pt devel chicken pox;no further details were provided;
by the middle of the month of May of 2021 his voice began going away & he still does not have it back; This spontaneous case was reported by a consumer and describes the occurrence of APHONIA (by the middle of the month of May of 2021 his voice began going away & he still does not have it back) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037A21B and 021C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In May 2021, the patient experienced APHONIA (by the middle of the month of May of 2021 his voice began going away & he still does not have it back). At the time of the report, APHONIA (by the middle of the month of May of 2021 his voice began going away & he still does not have it back) had not resolved.            No concomitant medications and no treatment medications were reported. It was reported that patient friend sent him an article about someone else who lost their voice after receiving 2nd dose.
Rash on extremities, maculopapular with erythema and pruritis. Taking Benadryl and topical Benadryl.
Visiting family over Christmas and began having scratchy throat. A family member tested positive so I tested and tested positive for COVID-19. Had cough, congestion, sore throat, headache, fatigue, runny nose, loss of appetite, upset stomach. Did x-ray and it was negative for pneumonia.  PCP prescribe Paxlovid and it didn't provide any relief for me. Symptoms persisted for about 6 weeks before beginning to improve.
Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 48-year-old male patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On an unknown date, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications information was not reported. The reporter stated that because their facility has not been able to download the digital data logger, they have been put on hold by the State at the moment and cannot administer the Moderna COVID-19 vaccine to patients until an assessment by the State was made.  There had been no power outages that would have impacted the Moderna vaccine. However, she reiterates that because her facility was unable to download the digital data logger, they would need to treat this issue as a temperature excursion.  Reporter stated that no adverse reactions were reported by any patients. No treatment medication were provided.
Two days after taking the vaccination, the skin on the palms of my hands started peeling off.  I have a Stevens-Johnson's Syndrome reaction to certain antibiotics.  This experience was less severe but very similar in appearance.
This case was reported by a consumer via call center representative and described the occurrence of influenza in a 93-year-old female patient who received Influenza vaccine. Co-suspect products included ADVAIR DISKUS inhalation powder for difficulty breathing. Concurrent medical conditions included blood pressure high, leg syndrome and reflux esophagitis. Concurrent medications included unspecified heart medicine, unspecified blood pressure medicine, unspecified leg syndrome medicine, and unspecified reflux medication. Concomitant products included Pneumonia vaccine. In October 2014, the patient received Influenza vaccine. In 2014, the patient started ADVAIR DISKUS (inhaled) 250/50 ug 1 puff(s) twice daily (2 puff(s) daily). In February 2015, 122 days after receiving Influenza vaccine and several months after starting ADVAIR DISKUS, the patient experienced influenza, hoarseness and sputum increased. ADVAIR DISKUS was continued with no change. On an unknown date, the outcome of the influenza was recovering/resolving and the outcome of the hoarseness and sputum increased were not recovered/not resolved. It was unknown if the reporter considered the influenza, hoarseness and sputum increased to be related to Influenza vaccine. It was unknown if the reporter considered the influenza to be related to ADVAIR DISKUS. The reporter considered the hoarseness and sputum increased to be possibly related to ADVAIR DISKUS. Additional information was provided: The patient reported that she had been using ADVAIR for about 23 years, but just last year, in 2014 started using it consistently and twice daily for her breathing. She stated in October of last year she had the flu shot, but in February 2015 she got the flu. Also in February with the flu incident she noticed voice changes and her doctor informed her it probably was the ADVAIR use. She stated she rinses her mouth after each dose. She also added that she has had increased fluid/mucous that she has to spit out. She was referred to her physician for treatment recommendations for the hoarseness. She added that she had also received the pneumonia vaccine at some point.
Patient got extremely agitated and cried all the time for 2 weeks, he also had a fever of about 104 for 4 days and got a really bad cough 3 days after the shot.
swelling in throat-mild difficulty swallowing; redness, puffiness, & dryness of eyes; no previous h/o allergy to eggs;
Noticed lump in right arm, size of quarter, red and painful, approx. 6 cm below right deltoid. Had nausea and vomiting day before noticing the lump.
However found out today a friend's brother had the same issue after 1st shot. He also started feeling bad 5 days after 1st shot and broke out with Shingles at 10 days; feeling bad 5 days after 1st shot; This is a spontaneous report from a contactable consumer. This consumer reported for a male patient (friend's brother). A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection; Batch/Lot Number: Unknown, Expiration date: Unknown) via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date the patient experienced shingles. It was reported by the consumer that Reporter found out today a friend's brother had the same issue after 1st shot. he also started feeling bad 5 days after 1st shot and broke out with shingles at 10 days. The outcome of the events were unknown.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021265079 same reporter/product/event, different patient
Patient was admitted to hospital on 12/12/2013 as a transfer from an outside hospital with intussusception.
SkinRash, Rash & UrticariaPruritus Narrative: Intermittent, body and facial rash with pruritis. She was evaluated by PCP on 1/5/21 and treated with Prednisone.
Pt. Refers to dizziness, malaise and presents paleness and sweating minutes after administering his third dose. Paramedic estimated vital: P: 72 B/P: 60/30 Sat: 97 Dextrose: 99 consultation with Dr. Oxygen is administered, he lay down with raised legs and observed for 30 minutes. Vitals were re-estimated P: 90 B/P: 115/70 Dextrose: 99 Patient reported feeling better and left.